Multiple Choice
FISH technology:
A) uses recombinant DNA technology.
B) detects hematopathologic chromosomal abnormalities.
C) detects oncogenic chromosomal abnormalities.
D) all of the above.
Correct Answer:

Verified
Correct Answer:
Verified
Q3: Match the following emerging technology with the
Q7: Match the assays and definitions.<br>-Inhibition immunofluorescent assay<br>A)Antibodies
Q12: Match the assays and definitions.<br>-Direct immunofluorescent assay<br>A)Antibodies
Q14: In fluorescent antibody microscopy using a fluorescent
Q19: Match the type of enzyme immunoassay (EIA)
Q20: Match the type of enzyme immunoassay (EIA)
Q21: Match the chemiluminescent format with the appropriate
Q22: Match the following emerging technology with the
Q23: Indirect immunofluorescent assay (IFA)is widely used for
Q26: Fluorescent molecules in immunofluorescent techniques are used